BioXcel Corporation is a biopharmaceutical company focusing on the application of artificial intelligence and big data analytics integrated with drug development expertise. It develops PharmGPS, a predictive cognitive intelligence platform that helps to design, develop, and commercialize new treatments. The company aims to develop medicines in immuno-oncology, neuroscience, and rare diseases.